Arcellx, Inc.
ACLX • NASDAQ
Arcellx, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Rami Elghandour, with a market cap of $6.7B.
CEORami Elghandour
Next Earnings
Upcoming earnings announcement for Arcellx, Inc.
Date
Thursday, May 7, 2026 (in a month)
Timing
After Market Close (4:00 PM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$1.06
Revenue Estimate
$6.2M
Earnings History
Past 12 earnings reports for Arcellx, Inc.
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Nov 5, 2025 | Q3 2025 | -$0.99Est: -$1.00 | +1.0% | $4.9MEst: $12.0M | -58.9% |  10-Q |
| Aug 7, 2025 | Q2 2025 | -$0.94Est: -$1.03 | +8.7% | $7.6MEst: $15.1M | -49.8% | 10-Q |
| May 8, 2025 | Q1 2025 | -$1.13Est: -$0.74 | -52.7% | $8.1MEst: $19.5M | -58.3% | 10-Q |
| Feb 27, 2025 | Q4 2024 | -$0.87Est: -$0.48 | -81.3% | $15.3MEst: $25.5M | -40.1% | 10-K |
| Nov 7, 2024 | Q3 2024 | -$0.48Est: -$0.47 | -2.1% | $26.0MEst: $31.8M | -18.2% | 10-Q |
| Aug 8, 2024 | Q2 2024 | -$0.51Est: -$0.55 | +7.3% | $27.4MEst: $21.8M | +25.9% | 10-Q |
| May 9, 2024 | Q1 2024 | -$0.14Est: -$0.51 | +72.5% | $39.3MEst: $20.7M | +89.9% | 10-Q |
| Feb 28, 2024 | Q4 2023 | $0.42 | — | $63.1M | — | 10-K |
| Nov 13, 2023 | Q3 2023 | -$0.81Est: -$0.65 | -24.6% | $15.0MEst: $11.2M | +33.3% | — |
| Aug 14, 2023 | Q2 2023 | -$0.50Est: -$0.31 | -61.3% | $14.3MEst: $40.6M | -64.7% | 10-Q |
| May 8, 2023 | Q1 2023 | -$0.58Est: $1.82 | -131.9% | $17.9MEst: $103.3M | -82.7% | — |
| Mar 29, 2023 | Q4 2022 | -$0.76Est: -$0.40 | -90.0% | - | — | — |